Details for Patent: 8,071,648
✉ Email this page to a colleague
Which drugs does patent 8,071,648 protect, and when does it expire?
Patent 8,071,648 protects NEVANAC and is included in one NDA.
This patent has twenty-seven patent family members in twenty-three countries.
Summary for Patent: 8,071,648
| Title: | Topical nepafenac formulations |
| Abstract: | Topical suspension compositions of nepafenac are disclosed. The compositions are especially suitable for topical ophthalmic administration. |
| Inventor(s): | Wong; Warren (Fort Worth, TX) |
| Assignee: | Novartis AG (Basel, CH) |
| Application Number: | 12/888,631 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 8,071,648
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Harrow Eye | NEVANAC | nepafenac | SUSPENSION/DROPS;OPHTHALMIC | 021862-001 | Aug 19, 2005 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,071,648
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Argentina | 052252 | ⤷ Sign Up | |||
| Austria | E476200 | ⤷ Sign Up | |||
| Australia | 2005311738 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
